| Financial Year |
March 31 2023 |
| Monetary Funds |
109,186,525.32 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
20,937,204.93 |
| Accounts Receivable |
538,069,944.22 |
| Advances to Suppliers |
45,578,316.71 |
| Other Receivables |
13,519,960.48 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
427,779,584.07 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
39,717.14 |
| Other Current Assets |
5,784,396.54 |
| Total Current Assets |
1,184,572,229.52 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
13,778,122.01 |
| Investment Properties |
36,287,752.37 |
| Fixed Assetes |
689,083,485.90 |
| Under-construction Projects |
89,337,725.43 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
71,451,470.75 |
| R&D expenses |
-- |
| Goodwill |
309,433,479.05 |
| Long-Term Deferred and Prepaid Expenses |
23,134,980.91 |
| Deferred Income Tax Assets |
17,621,828.47 |
| Other Non-Current Assets |
1,491,682.26 |
| Sub-Total of Non-Current Assets |
1,349,573,514.93 |
| Total Assets |
2,534,145,744.45 |
| Short-Term Loans |
371,573,556.23 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
225,088,008.56 |
| Accounts Received In Advance |
3,275,899.75 |
| Employee Compensation Payable |
40,195,920.02 |
| Taxes Payable |
12,392,512.79 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
41,538,327.15 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
2,015,041.84 |
| Other Current Liabilities |
333,596.04 |
| Sub-Total of Current Liabilities |
705,283,942.57 |
| Long-term Loans |
94,600,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
42,969,528.67 |
| Special Payable |
-- |
| Estimatied Liabilities |
834,686.68 |
| Deferred Income Tax Liabilities |
9,165,765.77 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
236,712,642.67 |
| Total Liabilities |
941,996,585.24 |
| Paid-In Capital(Or Share Stock) |
499,780,023.00 |
| Capital Surplus |
448,856,035.96 |
| Surplus Reserve |
6,713,358.08 |
| LESS:Treasury Stock |
50,022,051.84 |
| Undistributed Profits |
611,781,202.11 |
| Minority Stockholder's Interest |
75,053,219.06 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,517,095,940.15 |
| Owner's Equity（Stockholder's Equity） |
1,592,149,159.21 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,534,145,744.45 |
